Table 2.

P-values of the rate of change of MT2A-expression.

Treatment	p-value	Adj. p.value
siRNA-comb MT2A	5.289 × 10–7	9.917 × 10–7
siRNA1 MT2A	5.289 × 10–7	9.917 × 10–7
siRNA2 MT1A	5.289 × 10–7	9.917 × 10–7
siRNA2 MT2A	5.289 × 10–7	9.917 × 10–7
siRNA3 MT2A	5.289 × 10–7	9.917 × 10–7
siRNA4 MT1A	1.997 × 10–7	9.917 × 10–7
siRNA4 MT1B	5.289 × 10–7	9.917 × 10–7
siRNA4 MT2A	5.289 × 10–7	9.917 × 10–7
siRNA2 MT1B	1.582 × 10–5	2.637 × 10–5
siRNA1 MT1B	1.784 × 10–5	2.677 × 10–5
siRNA1 MT1A	2.560 × 10–5	3.491 × 10–5
siRNA-comb MT1B	6.050 × 10–4	7.562 × 10–4
siRNA3 MT1A	5.806 × 10–3	6.699 × 10–3
siRNA3 MT1B	1.305 × 10–2	1.398 × 10–2
siRNA-comb MT1A	9.857 × 10–1	9.857 × 10–1

Significant reduction of MT2A expression could be detected with a median estimate of 73% (confidence interval (95%) between 64 and 79%). P-values were FDR-adjusted.